A study of the nature of pilocarpine inhibition of hepatic drug-metabolizing enzymes.
D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006591:Hexobarbital / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D009538:Nicotine / Q000378:metabolism; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010862:Pilocarpine / Q000494:pharmacology*; D011817:Rabbits
D010862:Pilocarpine; D009538:Nicotine; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D005954:Glucosephosphate Dehydrogenase; D009251:NADPH-Ferrihemoprotein Reductase